tiprankstipranks
Trending News
More News >
AbCellera Biologics (ABCL)
NASDAQ:ABCL

Compare AbCellera Biologics (ABCL) vs. Competitors

Compare
2,299 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
AbCellera Biologics
$3.40
$1.03B
-6.98
42.86%
4 Buy
0 Hold
0 Sell
Strong Buy
Syndax Pharmaceuticals
$24.23
$2.14B
-6.38
71.84%
8 Buy
0 Hold
0 Sell
Strong Buy
Arcus Biosciences
$21.64
$2.71B
138.59%
7 Buy
3 Hold
0 Sell
Moderate Buy
Dianthus Therapeutics
$77.76
$3.46B
-9.59
280.43%
15 Buy
0 Hold
0 Sell
Strong Buy
Edgewise Therapeutics
$29.06
$3.12B
-12.72
22.00%
8 Buy
1 Hold
0 Sell
Strong Buy
Structure Therapeutics, Inc. Sponsored ADR
$48.59
$3.44B
31.19
122.18%
13 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ABCL
AbCellera Biologics
3.40
0.81
31.27%
SNDX
Syndax Pharmaceuticals
24.23
10.50
76.47%
RCUS
Arcus Biosciences
21.64
12.52
137.28%
DNTH
Dianthus Therapeutics
77.76
58.35
300.62%
EWTX
Edgewise Therapeutics
29.06
5.69
24.35%
GPCR
Structure Therapeutics, Inc. Sponsored ADR
48.59
27.54
130.83%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts